Emotional Benefits of Probiotics; Phase III Success for ADHD Tx | MedPage Today
Probiotics paired with prebiotics may hold a place in depression and anxiety treatment regimens, according to a review of seven studies. (The BMJ)
The investigational treatment vafidemstat-- an oral KDM1A inhibitor -- effectively reduced aggression in patients with borderline personality disorder, ADHD, and autism in the phase IIa Reimagine trial, Oryzon Genomics announced.
Sunovion said its SEP-4199 amisulpride formulation failed to meet its primary endpoint after six weeks in a phase II trial targeting major depressive episodes associated with bipolar I disorders..
https://www.medpagetoday.com/psychiatry/generalpsychiatry/87463
Comments
Post a Comment